Related Experiment Video

Updated: Jun 30, 2026

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
07:43

Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients

Published on: September 25, 2018

10.5K

Give Patients the Choice to Test for DPD Deficiency Before Fluoropyrimidine Chemotherapy

Ken Surprenant1, Lindsay Murray1, Karen Merritt1

  • 1Ken Surprenant, MA, Advocates for Universal DPD/DPYD Testing, Battle Creek, MI; Lindsay Murray, HS, Advocates for Universal DPD/DPYD Testing, Andover, MA; Karen Merritt, BS, Advocates for Universal DPD/DPYD Testing, Chelan, WA; Maria Hopkins, BS, Advocates for Universal DPD/DPYD Testing, Battle Creek, MI; and Joanne McIntyre, AA, Advocates for Universal DPD/DPYD Testing, Portland, OR.

JCO Oncology Practice
|December 3, 2024
PubMed
Summary

Before starting fluoropyrimidine (FU) and capecitabine (Xeloda) chemotherapy, patients should determine if DPYD screening is appropriate for them. This personalized approach ensures informed decision-making regarding genetic testing for chemotherapy treatment.

More Related Videos

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection07:35

Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Published on: June 8, 2020

6.9K
Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

626

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...